NCT04155684View on ClinicalTrials.gov

Dysbiosis Impact on Lung Disease in HIV

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
HIV InfectionsCOPDMicrobiome
Trial Locations (1)

15213

University of Pittsburagh, Pittsburgh

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Pittsburgh

OTHER

NCT04155684 - Dysbiosis Impact on Lung Disease in HIV | Biotech Hunter | Biotech Hunter